ADD Advanced Drug Delivery Technologies Ltd
Company Overview
Management
Hans Lötscher
Härkingen
Member of the board
Joint signing authority (any two to sign)
Reinhard Nowak
Binzen, DE
Chairperson of the board
Individual signing authority
Oskar Heiniger
Oberwil
Member of the board
Joint signing authority (any two to sign)
Jay Nowak
Lörrach, DE
Member of the board
Individual signing authority
Peter Fankhauser
Ettingen
Chairperson of the board
Joint signing authority (any two to sign)
Peter van Hoogevest
Bubendorf
Managing member of the board
Joint signing authority (any two to sign)
Peter Wolf
Pratteln
Member of the board
Joint signing authority (any two to sign)
Diethelm Wyrsch
Marly
Member of the board
Joint signing authority (any two to sign)
Prof. Fahr
Cölbe(D)
Joint signing authority (any two to sign)
Manfred Kohlmeyer
Basel
Joint signing authority (any two to sign)
Hans Leuenberger
Pfeffingen
Joint signing authority (any two to sign)
Burkhard Schlütermann
Merzhausen
Joint signing authority (any two to sign)
Dr. Tiemessen
Weil am Rhein
Joint signing authority (any two to sign)
Helmut Anscheringer
Basel
Member of the board
Joint signing authority (any two to sign)
Steve Leigh
Croydon
Member of the board
Joint signing authority (any two to sign)
Reinhard Nowak
Binzen
Member of the board
Joint signing authority (any two to sign)
Reinhard Nowak
Binzen
Manager
Joint signing authority (any two to sign)
Armin Prasch
Merzhausen
Manager
Joint signing authority (any two to sign)
Paul Senn
Bennwil
Manager
Joint signing authority (any two to sign)
Peter Neuwirth
Zürich
Member of the board
Joint signing authority (any two to sign)
Building smart people network graph...
Fetching people and their companies
Address & Locations
Primary Address
Loading map...
| No. | Journal No. | Journal date | SOGC | SOGC date | Page / ID |
|---|---|---|---|---|---|
| 1 | 1407 | 13.03.2020 | 54 | 18.03.2020 | 1004855426 |
| 2 | 6645 | 20.12.2016 | 250 | 23.12.2016 | 3244095 |
| 3 | 4406 | 02.10.2014 | 193 | 07.10.2014 | 1755223 |
| 4 | 5039 | 30.10.2012 | 214 | 02.11.2012 | 6915888 |
| 5 | 5511 | 30.11.2010 | 237 | 06.12.2010 | 6/5925342 |
| 6 | 7928 | 30.12.2009 | 3 | 06.01.2010 | 5/5428260 |
| 7 | 6141 | 02.12.2008 | 238 | 08.12.2008 | 6/4768256 |
| 8 | 503 | 25.01.2008 | 21 | 31.01.2008 | 5/4316714 |
| 9 | 262 | 14.01.2008 | 12 | 18.01.2008 | 5/4295364 |
| 10 | 3128 | 14.07.2004 | 138 | 20.07.2004 | 5/2369326 |
Company Purpose
Die Gesellschaft bezweckt den Verkauf und den Vertrieb von Technologien pharmazeutischer Darreichungsformen und pharmazeutischer Präparate und ebenso Dienstleistungen sowie das Erwerben, Halten, Verwalten, Veräussern und Vergeben von Lizenzen in diesen Bereichen. Die Gesellschaft kann Zweigniederlassungen und Tochtergesellschaften im In- und Ausland errichten und sich an anderen Unternehmen im In- und Ausland beteiligen. Die Gesellschaft kann Grundstücke erwerben, halten und veräussern. Die Gesellschaft kann alle kommerziellen, finanziellen und anderen Tätigkeiten ausüben, welche mit dem Zweck der Gesellschaft im Zusammenhang stehen.